INTEGRATED BIOPHARMA INC Deferred Tax Assets, Operating Loss Carryforwards
INTEGRATED BIOPHARMA INC (INBP) had Deferred Tax Assets, Operating Loss Carryforwards of $4.37 million as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-09-23
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $4.37M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $5.03M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $5.11M.
- 2022-06-30: Deferred Tax Assets, Operating Loss Carryforwards $5.17M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-06-30 | $4.37M 10-K · filed 2025-09-23 |
| 2024-06-30 | $5.03M 10-K · filed 2025-09-23 |
| 2023-06-30 | $5.11M 10-K · filed 2024-09-20 |
| 2022-06-30 | $5.17M 10-K · filed 2023-09-15 |
| 2021-06-30 | $5.69M 10-K · filed 2022-09-13 |
| 2020-06-30 | $7.05M 10-K · filed 2021-09-02 |
| 2019-06-30 | $7.64M 10-K · filed 2020-09-23 |
| 2018-06-30 | $8.25M 10-K · filed 2019-08-29 |
| 2017-06-30 | $13.31M 10-K · filed 2018-09-12 |
| 2016-06-30 | $13.97M 10-K · filed 2017-09-01 |
| 2015-06-30 | $14.31M 10-K · filed 2016-09-02 |
| 2014-06-30 | $14.66M 10-K · filed 2015-09-04 |
| 2013-06-30 | $14.79M 10-K · filed 2014-09-08 |
| 2012-06-30 | $14.61M 10-K · filed 2013-09-30 |
| 2011-06-30 | $13.27M 10-K · filed 2012-10-15 |